Background—Lymphocytic colitis is characterised by chronic watery diarrhoea ... Considering the benign course of the disease, the potential benefit of any drug treatment should be carefully weighed ...

The tolerability of budesonide was good and no differences in ... where the remission rate of 48% in placebo-treated patients with lymphocytic colitis was higher than in RCTs of patients with ...

Collagenous colitis, a cause of chronic diarrhea, is treated with a wide variety of compounds, most of which have not been tested in randomized controlled trials. A recent systematic review from ...

Conclusions Budesonide at a mean dose of 4.5 mg/day maintained clinical remission for at least 1 year in the majority of patients with collagenous colitis and preserved health-related quality of life ...